Renata Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Renata Limited with three other
pharmaceutical manufacturers in Asia:
sales of 28.38 billion Japanese Yen [US$268.80 million]
of which 77%
was Pharmaceutical Products),
Beximco Pharmaceuticals Limited
(22.82 billion Bangladeshi Taka [US$269.24 million]
Daewon Pharmaceutical Co Ltd
based in KOREA (SOUTH)
(317.83 billion Korean Won [US$270.15 million]
of which 99%
Renata Limited reported sales of 22.81 billion Bangladeshi Taka (US$269.15 million)
June of 2019.
increase of 19.7%
versus 2018, when the company's sales were 19.05 billion Bangladeshi Taka.
Sales at Renata Limited have increased during each of the previous five years
(and since 2014, sales have increased a total of 100%).